Skip to main content
Clinical Trials/NCT01797016
NCT01797016
Completed
Not Applicable

Comparing Blood Count Test Measures to Flow Cytometry in Healthy Patients to Acute General Syndrome Patients

Ziv Hospital1 site in 1 country59 target enrollmentJanuary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
Ziv Hospital
Enrollment
59
Locations
1
Primary Endpoint
Detection of platelet-leukocyte aggregates by routine blood count.
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

This project aims to refine previous studies including the investigators work recently published in August 2012 Journal Thrombosis and Thrombolysis. That study showed a relationship between the level of platelet leukocyte aggregates in patients with acute coronary syndrome. The investigators intend to compare the characteristics of platelets, monocytes and neutrophil data of volume, scatter and conductivity obtained from routine blood count level with flow cytometry results defining platelet leukocyte aggregates. The investigators hypothesize that there will be a direct correlation between elevated platelet-leukocyte aggregates and biophysical data from the blood count.

Detailed Description

The goal is to investigate whether there is a simple and inexpensive method to test the level of platelet leukocyte aggregates through the blood count test. The parameters which are obtained routinely for white blood cell counts include: capacity - electrical conductivity (conductivity) - dispersion (scatter), and volume. Though these values are not reported routinely, they can be accessed for each blood count. The premise is that through blood counts (no need for specialized flow cytometry) and through the parameters mentioned a conclusion can be reached about platelet leukocyte aggregates. This will then aid in prognosis about the risk of an acute event for every patient with ischemic heart disease who comes to the emergency room.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
September 2014
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Ziv Hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr. Najib Dally

Head of Hematology Institute

Ziv Hospital

Eligibility Criteria

Inclusion Criteria

  • Signed consent form, over 18 years of age, diagnosis of STEMI or non-STEMI as per following:
  • Acute ST Elevation Myocardial Infarction (STEMI) was diagnosed in patients with high level of troponin I (\>0.4 ng/ml), ST segment elevation in at least two contiguous leads of the ECG (or new LBBB) and/or ischemic chest pain.
  • Acute Non ST Elevation Myocardial Infarction (Non STEMI) was diagnosed if level of troponin I was \> 0.4 ng/ml, patient had ischemic chest pain or ST-T depression and/or T-wave inversion on ECG.

Exclusion Criteria

  • Inability to sign consent form, under 18, participation in other research projects within previous 6 months.

Outcomes

Primary Outcomes

Detection of platelet-leukocyte aggregates by routine blood count.

Time Frame: 1 year

Study Sites (1)

Loading locations...

Similar Trials